scholarly article | Q13442814 |
P50 | author | Mosheng Yu | Q89619119 |
P2093 | author name string | Siyang Liu | |
Ting Wan | |||
Yueqiang Zhao | |||
Zhanyong Zhu | |||
Luocheng Li | |||
P2860 | cites work | Advanced glycation end-products inhibition improves endothelial dysfunction in rheumatoid arthritis | Q83422954 |
[New options for therapeutic revascularization in lower extremity limb ischemia linked to the diabetic foot syndrome by autologous stem cell transplantation] | Q86107043 | ||
Clinical Evaluation of Human Umbilical Cord Mesenchymal Stem Cell Transplantation After Angioplasty for Diabetic Foot | Q89274122 | ||
C-reactive protein down-regulates endothelial nitric oxide synthase expression and promotes apoptosis in endothelial progenitor cells through receptor for advanced glycation end-products | Q28579621 | ||
Scorpine, an anti-malaria and anti-bacterial agent purified from scorpion venom | Q30858430 | ||
Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates | Q33447111 | ||
Cloning and functional characterization of a new antimicrobial peptide gene StCT1 from the venom of the scorpion Scorpiops tibetanus | Q33512221 | ||
Cellular and molecular basis of wound healing in diabetes | Q34625159 | ||
Healing effects of Musa sapientum var. paradisiaca in diabetic rats with co-occurring gastric ulcer: cytokines and growth factor by PCR amplification | Q34657189 | ||
Candesartan restores pressure-induced vasodilation and prevents skin pressure ulcer formation in diabetic mice | Q35382532 | ||
Peptide antimicrobial agents | Q36538861 | ||
Mucroporin, the first cationic host defense peptide from the venom of Lychas mucronatus | Q36949473 | ||
Immune mediators in patients with acute diabetic foot syndrome | Q37269418 | ||
The role of hyperbaric oxygen in the treatment of diabetic foot ulcers | Q37923225 | ||
Non-healing foot ulcers in diabetic patients: general and local interfering conditions and management options with advanced wound dressings | Q38411573 | ||
Antibacterial Activity and Toxicity of Analogs of Scorpion Venom IsCT Peptides | Q38705148 | ||
An Assessment of Intralesional Epidermal Growth Factor for Treating Diabetic Foot WoundsThe First Experiences in Turkey | Q38921590 | ||
Bioactivity of Natural and Engineered Antimicrobial Peptides from Venom of the Scorpions Urodacus yaschenkoi and U. manicatus | Q40379786 | ||
Predictive Value of Soluble CD14, Interleukin-6 and Procalcitonin For Lower Extremity Amputation in People with Diabetes with Foot Ulcers: A Pilot Study. | Q40408091 | ||
AMPer: a database and an automated discovery tool for antimicrobial peptides. | Q42613788 | ||
Clinical observation of the application of autologous peripheral blood stem cell transplantation for the treatment of diabetic foot gangrene | Q43060122 | ||
IsCT, a novel cytotoxic linear peptide from scorpion Opisthacanthus madagascariensis. | Q43718048 | ||
Antibacterial and antifungal properties of alpha-helical, cationic peptides in the venom of scorpions from southern Africa. | Q44158394 | ||
The pathological effects of Heminecrolysin, a dermonecrotic toxin from Hemiscorpius lepturus scorpion venom are mediated through its lysophospholipase D activity | Q46743974 | ||
Hadrurin, a new antimicrobial peptide from the venom of the scorpion Hadrurus aztecus | Q50119975 | ||
Skin necrosis after filler-associated vascular compromise: successful treatment with topical epidermal growth factor. | Q54292410 | ||
[Diabetic foot: from diagnosis to therapy] | Q81565113 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P304 | page(s) | 5161565 | |
P577 | publication date | 2017-10-29 | |
P1433 | published in | Evidence-based Complementary and Alternative Medicine | Q5418319 |
P1476 | title | Scorpion Venom Active Polypeptide May Be a New External Drug of Diabetic Ulcer | |
P478 | volume | 2017 |
Q90601800 | Antiinflammatory peptides: current knowledge and promising prospects | cites work | P2860 |
Search more.